TOPLINE: The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high specificity and sensitivity. The assay showed improved detection of early-stage cancer when combined with carbohydrate antigen 19-9 (CA 19-9). METHODOLOGY: CA 19-9, the only Food and Drug Administration–approved biomarker for PDAC…
Leave a Comment Leave a Comment
